Select Pharma, the Dunblane-based laboratory testing company, has been acquired for up to £7.3million by main market-listed Source Bioscience.
It represents a £5million windfall for majority shareholder David Clapperton whose wife Morag is also on the board, and a £1.8m payout for Gerald Higgins, chairman since 2013.
Privately-owned Select, founded in November 2009, provides stability storage and testing laboratory services, and three years ago it moved its testing facilities to the BioCity Scotland business incubator site at Newhouse in Lanarkshire.
The company doubled revenues to £2m and net assets to £1.3m over the two years to March 2014, and lifted pre-tax profit from £453,000 to £578,000. Its cash flow from operations more than doubled to £643,000 between 2013 and 2014, and it is debt-free.
Source, based in Nottingham and with a market capitalisation of £46million, said the Scottish firm had continued on the same track in the past year. “Select has grown consistently in recent years to become a leading European provider of stability testing with attractive, sustained operating margins and a robust, growing sales pipeline.”
Select's customers include contract drug manufacturers, European generics distributors and UK and EU importers of medicinal products, amid growing demand for accredited testing to support drug import licence applications, and it is located close to Source Bioscience's Scottish base.
Source has raised £4.4m from investors in a placing, and £3.5m in new debt, to finance the £7.3m in cash, of which £600,000 is deferred for two years.
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here